جستجوی استاد راهنمای دانشگاهی

• Artificial Intelligence
• Machine Learning
• Medical Imaging
• +۳ مورد دیگر

Professor Daniel Rueckert is a leading academic in Artificial Intelligence and Medical Imaging, holding dual positions at Imperial College London (as Professor of Visual Information Processing) and Technical University of Munich (Alexander von Humboldt Professor for AI in Medicine and Healthcare). He obtained his MSc from Technical University Berlin (1993) and PhD from Imperial College London (1997), followed by postdoctoral work at King’s College London. At Imperial, he led the Department of Computing (2016–2020) and founded the Biomedical Image Analysis group. His research focuses on AI-driven medical image analysis, including algorithms for image reconstruction, registration, and clinical decision support. His research interests span AI applications in healthcare, machine learning for medical imaging, and computational methods for clinical diagnostics. Notable contributions include over 500 publications and 60+ PhD graduates, with key works in federated learning, cardiac motion analysis, and biomarker development. Awards include the Leibniz Prize (2025), Royal Academy of Engineering Fellowship (2015), and multiple ERC grants. He leads the BioMedIA research group and is an editorial board member of Medical Image Analysis . Recent publications highlight advancements in AI-driven medical imaging, such as secure federated learning frameworks and deep learning models for disease prediction. His work bridges academic and industrial sectors through initiatives like IXICO, an Imperial spin-out. Current affiliations include roles at both Imperial and TUM, emphasizing interdisciplinary collaboration in healthcare technology. Advising and grants: Supervised over 60 PhD students and 40 post-docs. Secured grants including ERC Synergy (2013) and ERC Advanced (2020). Active in labs focused on biomedical image computing and AI in healthcare systems. Collaborative efforts include the BioMedIA group and TUM’s AI initiatives. Labs/teams: Leads the Biomedical Image Analysis group at Imperial and the TUM AI in Medicine team. Collaborates extensively on projects like cardiac imaging analysis and federated learning for healthcare.

Chris Simpsonمشاهده پروفایل

استاد

• Health Policy
• Cardiology
• Medical Imaging AI
• +۷ مورد دیگر

Dr. Chris Simpson is a Professor at Queen’s University and currently serves as Executive Vice President & Chief Medical Executive at Ontario Health. He previously held roles as Head of Cardiology (2006-2016) and Vice-Dean (Clinical) of the Faculty of Health Sciences (2016-2021). His expertise spans cardiology, health policy, and medical imaging AI. Simpson has authored over 350 peer-reviewed publications and holds fellowships in multiple medical societies. His research focuses on health policy (access to care, wait times), cardiac electrophysiology, and AI-driven medical imaging. Education: BSc (University of New Brunswick), MD (Dalhousie University), Cardiac Electrophysiology Fellowship (University of Western Ontario). Notable roles include CMA President (2014-2015), CAHS President (2020-2021), and leadership in organizations like CorHealth and SEAMO. Awards include Fellowships in the Canadian Academy of Health Sciences and American College of Cardiology. Research interests include medical fitness to drive, atrial fibrillation, sudden cardiac death, and AI applications in oncology imaging. He leads initiatives such as the Terry Fox Research Institute’s Marathon of Hope Network. Simpson also contributes to policy bodies including Ontario Health’s Quality Standards Committee and the World Medical Association.

Jean-Philippe Coudercمشاهده پروفایل

دانشگاهی

• Physiological signal processing
• Medical software design
• Quantitative electrocardiography
• +۴ مورد دیگر

Dr. Jean-Philippe Couderc is a Research Assistant Professor of Medicine in the Cardiology Department at the University of Rochester Medical Center and Chief Technology Officer of iCardiac Technology Inc. He holds a PhD in Biomedical Engineering from the French National Institute of Applied Sciences (1997), an MBA in Healthcare Management from the Simon School of Business (2003), and an MS in Medical Specialties from a French institution (1994). His research focuses on quantitative electrocardiography, ventricular repolarization, and cardiac safety, with contributions to clinical study design and medical software development. He leads the Heart Research Follow-up Program Laboratory and serves on the editorial board of Annals of Non-Invasive Electrocardiology . Notable awards include the Frost & Sullivan Technology Innovation Award (2006) and the Mirowski-Moss Career Development Award (2003). His work spans federal grants, industry collaborations, and over 100 peer-reviewed articles. Research Interests: Dr. Couderc’s work integrates computational science, electrophysiology, and clinical cardiology to address challenges in cardiac safety, drug evaluation, and wearable health technologies. His lab develops novel ECG analysis tools and evaluates their application in arrhythmia monitoring, drug-induced QT prolongation, and non-invasive diagnostics. Publications: His recent work includes advancements in video-based cardiac monitoring, demographic factors in ECG patch usage, and biomarker identification for epilepsy and heart conditions. He co-authored key consensus statements on mHealth in arrhythmia management, emphasizing digital tools for heart rhythm professionals. Awards & Grants: Dr. Couderc has secured NIH and industry grants, leading projects on repolarization dynamics and cardiac resynchronization therapy. He advises on FDA drug evaluation and contributes to international clinical guidelines.

Biykem Bozkurtمشاهده پروفایل

استاد

• Heart Failure
• Cardiac Transplantation
• Cardiology
• +۳ مورد دیگر

Biykem Bozkurt is a Senior Dean of Faculty and Professor in the Department of Medicine-Cardiology at Baylor College of Medicine in Houston, Texas. She holds the Mary and Gordon Cain Chair of Internal Medicine and the W. A. 'Tex' and Deborah Moncrief, Jr. Chair. Her roles include leadership in academic administration and clinical cardiology. Education includes an MD from Istanbul Faculty of Medicine, Turkey, and a PhD in Cardiology from Baylor College of Medicine and the University of Texas Medical School. She completed residencies and fellowships in Internal Medicine and Cardiology at Baylor College of Medicine. Research focuses on heart failure, cardiac transplantation, and myocarditis, with contributions to clinical guidelines (e.g., AHA/ACC/HFSA) and translational studies. Her work addresses biomarkers, frailty in heart failure, and post-COVID cardiac complications. She is a leader in the Heart Failure Society of America, authoring epidemiology reports and consensus statements. Awards include prestigious chairs, and she contributed to high-impact studies such as the MYOFLAME-19 trial and SPRINT trial analyses. She actively participates in guideline development and cardiovascular policy.

Fabio Nobileمشاهده پروفایل

استاد

• Scientific Computing
• Uncertainty Quantification
• Numerical Analysis
• +۵ مورد دیگر

Fabio Nobile is a Full Professor at the École Polytechnique Fédérale de Lausanne (EPFL) in the School of Basic Sciences (SB), Department of Mathematics (MATH), holding the CADMOS Chair in Scientific Computing and Uncertainty Quantification. He leads the CSQI (Chair of Scientific Computing and Uncertainty Quantification) group. His work focuses on numerical methods for partial differential equations (PDEs), uncertainty quantification, stochastic modeling, and computational fluid dynamics. He is involved in collaborative projects involving fluid-structure interaction, cardiac electro-mechanics, and energy systems. Professor Nobile has extensive teaching experience, including courses on advanced analysis, stochastic simulation, and numerical integration of stochastic differential equations. He supervises numerous PhD students and has contributed to over 200 peer-reviewed publications, covering topics such as low-rank approximation methods, multilevel Monte Carlo techniques, and optimal control under uncertainty. His research emphasizes interdisciplinary applications, including biomedical engineering (e.g., personalized cardiac simulations) and renewable energy (e.g., probabilistic load forecasting). He collaborates with industries and academic institutions globally, advancing computational methodologies for engineering and scientific challenges.

Horng H. Chenمشاهده پروفایل

استاد

• Cardiorenal dysfunction
• Heart failure
• Natriuretic peptide therapeutics
• +۶ مورد دیگر

Horng H. Chen, M.D., is a board-certified adult heart failure cardiologist and physician-scientist at Mayo Clinic in Rochester, Minnesota, holding the position of Professor of Medicine in the Department of Cardiovascular Medicine at Mayo Clinic College of Medicine. Dr. Chen serves as Chair of the Division of Circulatory Failure and is the Co-Director of Mayo Clinic's Cardiorenal Research Laboratory, where he has established an independent research program in human cardiorenal physiology in heart failure. Primary Appointment: Consultant, Division of Circulatory Failure, Department of Cardiovascular Medicine Administrative Appointment: Chair, Division of Circulatory Failure, Department of Cardiovascular Medicine Academic Rank: Professor of Medicine Location: Rochester, Minnesota Dr. Chen is a board-certified cardiologist with subspecialty certification in heart failure and transplantation and adult comprehensive echocardiography. With over 20 years of experience in translational research, he has advanced the field of cardiorenal therapeutics in heart failure, filing 10 patents for cardiorenal syndrome therapeutics. His pioneering work has changed thinking in congestive heart failure and cardiorenal biology by advancing the concept of cardiac natriuretic peptides as cardiorenal protective properties via cyclic guanosine monophosphate (cGMP) signaling. He is pursuing subcutaneous administration of native and novel designer natriuretic peptides, along with nanotechnologies like nanoparticles with embedded natriuretic peptides. Cardiorenal dysfunction: Established and developed independent research program in human cardiorenal physiology in heart failure Natriuretic peptide therapeutics: Advanced concepts of cardiac natriuretic peptides as cardiorenal protective properties Novel therapies: Bridging laboratory discoveries to patient care for cardiorenal dysfunction Dr. Chen's research has significant clinical impact, particularly through the Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE-AHF) study, which changed management approaches for acute heart failure patients. His work continues to discover and translate novel therapeutics for heart failure with a translational focus through Mayo's Center for Clinical and Translational Studies Activities (CTSA). Elected member, The American Society for Clinical Investigation (2012) Stanford University Names World's Top 2% Scientists (2021) Multiple Jay N. Cohn Young Investigator Awards from the Heart Failure Society of America Cardiovascular Diseases Outstanding Achievement Award Mayo Clinic (2001) Mayo Foundation Scholar Mayo Clinic (2001) Dr. Chen has been continuously NIH-funded since 2005, currently serving as principal investigator on three NHLBI research grants and co-investigator on the NHLBI Heart Failure Clinical Research Network. His mentoring extends through the NIH/NHLBI Cardiovasology T32 Training Grant, supporting the development of young cardiovascular researchers in the Department of Cardiovascular Diseases. As Co-Director of the Cardiorenal Research Laboratory, Dr. Chen leads a team actively developing novel therapeutics for heart failure and cardiorenal syndrome. The laboratory collaborates closely with Mayo's Center for Clinical and Translational Studies Activities to translate discoveries from bench to bedside, with particular focus on advancing nanotechnologies for therapeutic applications in cardiovascular medicine.

Christopher R. Johnsonمشاهده پروفایل

دانشگاهی

• Scientific Computing
• Scientific Visualization
• Image Analysis
• +۳ مورد دیگر

Christopher R. Johnson is a Distinguished Professor of Computer Science and Founding Director of the Scientific Computing and Imaging (SCI) Institute at the University of Utah. He holds additional appointments as Research Professor of Bioengineering and Adjunct Professor of Physics. His research focuses on scientific computing, visualization, and biomedical applications, with notable contributions to software tools like SCIRun, ShapeWorks, and FluoRender. He has led the SCI Institute since its founding in 1992, growing it to over 200 members. Johnson has pioneered advancements in cardiac electrophysiology modeling, medical imaging, and high-performance computing. Johnson’s academic journey includes a B.S., M.S., and Ph.D. in Computer Science, though specific institutions are not mentioned. His editorial roles include co-editing The Visualization Handbook and serving on multiple journal boards. He has advised numerous students, including Brian Zenger, Jake Bergquist, and Lindsay Rupp, who have received prestigious awards like the NSF Graduate Research Fellowship. His awards span decades and disciplines, including the NSF Presidential Faculty Fellow Award, IEEE Visualization Career Award, and Utah Cyber Pioneer Award. He is a Fellow of AIMBE, AAAS, SIAM, and IEEE. Johnson’s work emphasizes translating computational methods into clinical tools, such as deep brain stimulation for Parkinson’s and atrial fibrillation treatment. Johnson’s lab, the SCI Institute, collaborates widely with industry and academia, developing open-source software for biomedical computing. Key projects include SCIRun (a biomedical problem-solving environment) and ShapeWorks (statistical shape modeling). He has been instrumental in securing over $6 million in NIH grants for the Center for Integrative Biomedical Computing (CIBC).

Cianflone Domenicoمشاهده پروفایل

دانشیار

• Cardiovascular Diseases
• Cardiology
• Cardiac Rehabilitation
• +۵ مورد دیگر

Cianflone Domenico is an Associate Professor of Cardiovascular Diseases at Vita-Salute San Raffaele University in Milan, Italy. He serves as Director of the Cardiac Rehabilitation Unit at San Raffaele Hospital and has held various clinical and academic positions throughout his distinguished career in cardiology. His educational background includes: Medical Degree with Honors, University of Milan (1980) Specialization in Cardiology, University of Milan (1982) Research Fellow, Cardiology Division, Royal Post-Graduate Medical School, Hammersmith Hospital, London (1983-1986) Honorary Fellowship, Duke University Medical Center, USA (1986) Professor Cianflone's research focuses on the causal mechanisms and precipitating factors of myocardial infarction and other coronary syndromes, innovative patient stratification models, and the development of Health IT/telemedicine solutions for cardiovascular care. His work bridges clinical cardiology with digital health technologies to improve cardiovascular disease prevention and management, with particular emphasis on cardiac rehabilitation, coronary artery disease mechanisms, and cardiovascular applications of health information systems. His recent publications demonstrate a strong emphasis on cardiac rehabilitation, postoperative cardiac complications, and the application of emerging technologies in cardiology. There's a clear trend toward exploring the intersection of traditional cardiology with digital health solutions, rehabilitation protocols, and personalized approaches to cardiovascular disease management, with numerous publications in high-impact journals like the International Journal of Cardiology. Professor Cianflone has held significant editorial positions including: Deputy Editor-in-Chief, International Journal of Cardiology (2016-present) Deputy Editor, International Journal of Cardiology: Hypertension (2018-present) Editorial Board, Italian Heart Journal (1998-2000) Editor-in-Chief, Medscape Italia Cardiologia (1999-2001) Professor Cianflone has supervised 24 degree theses and 12 specialization theses at UniSR, with four of these theses leading to Young Researcher awards and international recognitions from organizations like SISA, GICR, and the American College of Cardiology. He has coordinated or participated in 15 research projects funded by the European Commission, European Social Fund, European Space Agency, Ministry of Health, and Ministry of University and Scientific Research. Additionally, he has served as principal investigator in 15 international clinical trials related to cardiovascular disease and held numerous positions in international commissions at the European Society of Cardiology, American College of Cardiology, International Heart Health Society, and NIH. As Director of the Cardiac Rehabilitation Unit at San Raffaele Hospital, Professor Cianflone leads a multidisciplinary team focused on high-intensity rehabilitative care for patients following advanced cardiac surgery, structural heart procedures, and complex coronary syndromes. His unit provides comprehensive cardiovascular prevention and rehabilitation services with a focus on reducing global cardiovascular risk, including hypertension, dyslipidemia, and diabetes management.

Frank Spinaleمشاهده پروفایل

استاد

• Cardiovascular Remodeling
• Heart Failure
• Extracellular Matrix
• +۴ مورد دیگر

Frank Spinale is a Professor and Director of Research at the University of South Carolina School of Medicine Columbia. With a dual MD/PhD background, his career spans over three decades of translational cardiovascular research, primarily focused on heart failure and cardiac remodeling mechanisms. Education: BS in Biology from Northeastern University (1977-1979), MS in Biometry from Medical University of South Carolina (1982-1984), MD from Medical University of South Carolina (1990-1993) Research Focus: Cardiovascular remodeling, extracellular matrix biology, matrix metalloproteinases in heart failure Current Role: Director of Research at USC School of Medicine Columbia Dr. Spinale's research has centered on the role of extracellular matrix (ECM) alterations in cardiovascular disease, particularly the dysregulation between matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in heart failure progression. His work has established causal relationships between MMP activity and adverse myocardial remodeling, especially following myocardial infarction. His research spans from basic molecular mechanisms to clinical applications, including the development of diagnostic biomarker panels for heart failure risk stratification. Analysis of his publication record shows consistent research productivity over three decades, with recent work focusing on myocardial stiffness estimation, mitral valve pathology, and novel therapeutic approaches for cardiac remodeling. His research bridges basic science with clinical applications, maintaining strong translational focus throughout his career. Dr. Spinale has received NIH funding for his research on MMP/TIMP dynamics in heart failure and has contributed significantly to understanding the structural underpinnings of cardiac remodeling. His work has influenced both basic cardiovascular science and clinical approaches to heart failure management.

Anas Alaniمشاهده پروفایل

استادیار

• Cardiology
• Radiology
• Cardiovascular Imaging
• +۴ مورد دیگر

Anas Alani, MD is an Assistant Professor in both Medicine and Radiology at the School of Medicine, University of California, Los Angeles. His academic career spans cardiovascular medicine with a strong emphasis on advanced imaging techniques and coronary pathophysiology. Dr. Alani's research interests focus on: Cardiovascular imaging using computed tomography Coronary artery disease and atherosclerosis Diabetes-related cardiovascular complications Valvular heart disease and interventions Cardiovascular risk assessment in special populations Extra-coronary calcification patterns His scholarly work demonstrates expertise in applying advanced imaging modalities to understand cardiovascular pathophysiology and improve diagnostic accuracy. Dr. Alani has contributed significantly to the field of coronary plaque characterization, positive remodeling in smokers, and the application of CT angiography in various clinical scenarios including diabetes, HIV, and metabolic syndrome. Dr. Alani's publication record shows consistent productivity since 2013, with 24 publications through 2024. His work frequently appears in high-impact cardiology and radiology journals including the Journal of the American College of Cardiology, American Journal of Cardiology, and JACC: Cardiovascular Interventions. His research demonstrates methodological rigor with extensive use of CT angiography, intravascular ultrasound, and other advanced imaging techniques to quantify coronary plaque characteristics. Dr. Alani is currently serving as Principal Investigator for a clinical trial titled "Effect of Tirzepatide on progression of coronary atherosclerosis using MDCT" sponsored by Eli Lilly & Co. (2025-2026), indicating ongoing active research in diabetes and cardiovascular disease. His work frequently collaborates with Dr. Matthew Budoff and other cardiovascular imaging experts, contributing to multicenter studies including the DCCT/EDIC Research Group and Multicenter AIDS Cohort Study.

• Cardiac Electrophysiology
• Atrial Arrhythmias
• Ventricular Arrhythmias
• +۴ مورد دیگر

Dr. Kim Chan serves as a Clinical Senior Lecturer at the University of Sydney's Central Clinical School and holds a concurrent position as Staff Specialist in Cardiology and Cardiac Electrophysiology at Royal Prince Alfred Hospital. With formal training including a National Heart Foundation-funded PhD from the University of Sydney and a two-year postdoctoral clinical and research fellowship in Cardiac Electrophysiology at Loyola University Medical Center under Prof. David Wilber, Dr. Chan maintains active clinical and research roles in cardiac electrophysiology. Dr. Chan's research program focuses on cardiac electrophysiology , particularly atrial and ventricular arrhythmias , with significant contributions to understanding sleep disordered breathing connections to arrhythmia outcomes and advanced cardiac imaging techniques. Current work examines catheter ablation efficacy in structural heart disease, novel epicardial access methods, and vascular mechanisms in diabetes-related complications. The research portfolio demonstrates consistent productivity with publications spanning clinical trials, systematic reviews, and molecular investigations. Article analysis reveals strong emphasis on interventional electrophysiology (68% of recent publications), particularly catheter ablation techniques for complex arrhythmias, with growing focus on device-based therapies and translational vascular biology . Key trends include increasing multi-center trial participation, refinement of ablation protocols for challenging anatomies, and exploration of hormonal influences on vascular repair mechanisms. Top-Rated Abstract, Arteriosclerosis Thrombosis and Vascular Biology Council, American Heart Association 2011 RPA Hospital Medical Officers Association Patron’s Prize for Research 2011 RPA Cardiologists’ Award for Best Publication by Clinical Scientist 2010 Dr. Chan actively contributes to national guideline development, notably co-authoring the 2018 Australian clinical guidelines for atrial fibrillation management. While specific grant details aren't provided, the National Heart Foundation-funded PhD and ongoing hospital/university appointments indicate sustained research support. Current work involves multicenter trials including the CAAD-VT study comparing ablation versus drugs for ventricular tachycardia.

• Cardiac Electrophysiology
• Leadless Pacing
• Cardiac Resynchronization Therapy
• +۵ مورد دیگر

Eric M Bader, MD is an Associate Professor of Medicine in the Department of Cardiovascular Medicine at Yale School of Medicine, specializing in cardiac electrophysiology. He is a clinical cardiac electrophysiologist at Yale New Haven Hospital and a member of Yale's internationally recognized lead management team. Dr. Bader's clinical practice includes the implantation and management of cardiac devices such as pacemakers, implantable cardioverter defibrillators (ICDs) for prevention of sudden cardiac death, and cardiac resynchronization therapy (CRT) to treat heart failure. He also performs complex ablations of various arrhythmias including supraventricular and ventricular tachycardia, atrial fibrillation, and atrial flutter. His research interests focus on leadless pacing, cardiac resynchronization, and the heart rhythm impact of COVID-19 infection. Dr. Bader has been investigating how the pandemic has affected cardiac device management and heart rhythm disorders in patients with heart failure. Dr. Bader is board certified in Internal Medicine, Cardiovascular Diseases, Clinical Cardiac Electrophysiology, echocardiography, nuclear cardiology, and vascular imaging. He is a Fellow of the American College of Cardiology. Leo M. Davidoff Society Outstanding Achievement in the Teaching of Medical Students award Fellow of the American College of Cardiology Dr. Bader has been an attending physician in the Yale Electrophysiology & Cardiac Arrhythmia Program for the last five years. His work involves both clinical care and research aimed at improving outcomes for patients with complex cardiac rhythm disorders through advanced device therapy and ablation techniques.

• Cardiac Diseases
• Heart Failure
• Cardiovascular Epidemiology
• +۷ مورد دیگر

Professor John Cleland is a leading academic in cardiovascular medicine at the University of Glasgow, specializing in cardiac diseases with a focus on heart failure, iron deficiency, and metabolic health. He holds a professorial position in the Department of Cardiovascular & Metabolic Health within the College of Medical, Veterinary and Life Sciences. His research spans multiple areas including cardiac resynchronization therapy, biomarker analysis, and clinical trial design. Key collaborations involve groups such as the Heart Failure Association and the BIOSTAT-CHF consortium. Cleland has contributed to landmark trials like IRONMAN (evaluating iron therapy in heart failure) and RESHAPE-HF (mitral regurgitation interventions). Research interests prominently feature heart failure pathophysiology, iron deficiency management, and the interplay between diabetes and cardiovascular outcomes. His work integrates clinical practice with translational research, emphasizing evidence-based guidelines and cost-effectiveness analyses. Notable contributions include over 600 publications (as of 2025) in high-impact journals such as *European Journal of Heart Failure* and *Circulation*. His studies often address practical clinical questions like optimal diuretic use, biomarker utilization, and device therapies. Grants and funding sources are not explicitly listed, but his involvement in multinational trials suggests significant external support. He leads the Glasgow Heart Failure Centre, fostering multidisciplinary teams focused on translational cardiac research.

Bruce D. Johnsonمشاهده پروفایل

استاد

• Cardiovascular Medicine
• Respiratory Physiology
• Exercise Physiology
• +۴ مورد دیگر

Bruce D. Johnson, Ph.D., is a Professor of Medicine and Physiology at Mayo Clinic, holding appointments in the Department of Cardiovascular Medicine, Division of Preventive, Occupational, and Aerospace Medicine, and the Department of Physiology & Biomedical Engineering. His research focuses on heart-lung interactions in clinical and extreme environments, including chronic heart failure, exercise physiology, and wearable technology development. He leads the Mayo Clinic's Energy Balance Core Laboratory and has conducted field studies in Antarctica, high-altitude mountains, and with unique populations such as breath-hold divers and military pilots. Education: Ph.D. in Respiratory Physiology and Biodynamics from the University of Wisconsin, Madison; Fellowships in Anesthesia Research and Preventive Medicine. Research Interests: Human performance limits, environmental physiology, disease detection via noninvasive methods, and health technology innovation. His work integrates clinical research with industry partnerships to advance wearable devices for chronic disease monitoring. Notable projects include studies on high-altitude physiology funded by NSF and DOD collaborations. Grants & Projects: NIH-funded studies on pulmonary limitations in heart failure, NSF projects on Antarctic expeditions, and DOD-supported research on cardiac resynchronization therapy optimization. Dr. Johnson's 335+ peer-reviewed publications span cardiovascular medicine, respiratory physiology, and environmental health. He has received multiple NIH fellowships and awards for exceptional research contributions.

Weihua Zhouمشاهده پروفایل

دانشیار

• Health Informatics
• Medical Image Analysis
• Machine Learning
• +۳ مورد دیگر

Weihua Zhou is a Tenured Associate Professor at Michigan Technological University in the College of Computing, with affiliations in Applied Computing, Biomedical Engineering, Computer Science, Electrical and Computer Engineering, and Mathematical Sciences. He holds a PhD from Southern Illinois University Carbondale, an MS and B.Eng. from Wuhan University, and completed postdoctoral research at Emory University. Academic Positions : Tenured Associate Professor (2025–present), Tenure-Track Assistant Professor (2019–2025) at Michigan Tech; Nina Bell Suggs Endowed Professorship (2015–2019) at the University of Southern Mississippi. Research Interests : Focuses on medical imaging and health informatics , particularly machine learning applications in cardiovascular diagnosis , osteoporosis risk stratification , and senile dementia early detection . Additional work includes radiomics for COVID-19 severity assessment , federated learning in medical segmentation , and deep learning for proximal femur strength prediction . Scientific Awards : USM Nina Bell Suggs Endowed Professorship, USM College of Arts and Sciences Scholarly Research Award, American Heart Association Research Leaders Academy (2017, 2018), USM Butch Oustalet Distinguished Professorship Research Award. Lab & Tools : Leads the Medical Imaging & Informatics Lab (MIILab-MTU) and contributes to the NSF/MRI GPU Cluster. Open-sourced tools include KD4COVID19 for radiomics analysis and ECGTools for ECG classification.